Table: Sapporo Clinical Lab - 9-MTH group results

Sapporo Clinical Laboratory

12/02/2020 07:10

Feb 12 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2019        Dec 31, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             13.35               12.88            17.40    
                 (+3.6 pct)          (-2.3 pct)       (+2.0 pct)  
  Operating        729 mln             568 mln          824 mln   
                 (+28.4 pct)         (-24.4 pct)      (+1.1 pct)  
  Recurring        762 mln             586 mln          845 mln   
                 (+30.0 pct)         (-24.2 pct)      (+4.0 pct)  
  Net              495 mln             378 mln          552 mln   
                 (+30.8 pct)         (-26.5 pct)      (+5.6 pct)  
  EPS            144.78 yen          110.24 yen       161.45 yen  
  Ann Div                             10.00 yen        10.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             10.00 yen        10.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T